Marin’s largest hospital facility has just announced the opening of its $535 million replacement building project that kicked off five years ago.
Formerly called Marin General Hospital, new medical facility, dubbed Oak Pavilion, features 260,000 squar… […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Orpheris, a wholly-owned subsidiary of Ashvattha Therapeutics, a biotech company focused on developing novel hydroxyl dendrimer therapeutics (HDTs) to treat unmet medical needs in inflammatory, oncology and ocular… […]
– 96% of Patients Achieve Primary Endpoint of > 2 Log Decline in HDV RNA- 58% of Patients Below Limit of Quantitation or Undetectable at Week 24
PALO ALTO, Calif., Aug. 31, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused o… […]
SAN CARLOS, Calif. & BOULDER, Colo.–(BUSINESS WIRE)–Addario Lung Cancer Medical Institute (ALCMI) and Biodesix, Inc. today announced they will begin an observational study to prospectively evaluate the clinical utility of biomarkers, including th… […]
After steadily tightening its grip on Aimmune Therapeutics over the past four years, Nestlé is swooping in to take full control.
The Swiss food and drink conglomerate is anting up $2.6 billion to acquire Aimmune at $34.5 per share, 174% more than its c… […]
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2020 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced that management will … […]